Physician profile
Andre Gilbert
NPI 1639110885
$3,888.16
in general payments reported to CMS, 2019-2025
22 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,357 · 2020: $272 · 2021: $1,347 · 2022: $634 · 2023: $14.10 · 2024: $22.84 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $277.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,283.55 | 2021-2022 | |
| Boston Scientific Corporation | $1,110.00 | 2019-2023 | |
| Verathon INC. | $400.00 | 2021 | |
| Astellas Pharma US INC | $179.81 | 2019-2020 | |
| Lumenis, INC | $164.90 | 2019-2021 | |
| Ars Pharmaceuticals Operations, INC. | $103.15 | 2025 | Neffy |
| Dexcom, INC. | $95.00 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Coloplast Corp | $85.78 | 2022 | |
| Bard Access Systems, INC. | $77.59 | 2019 | |
| Richard Wolf Medical Instruments Corp. | $74.25 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $47.92 | 2020 | |
| Janssen Pharmaceuticals, INC | $40.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $37.50 | 2019 | |
| Allergan, INC. | $28.72 | 2019 | |
| Sumitomo Pharma America, INC. | $27.33 | 2025 | Orgovyx |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $23.93 | 2021 | |
| Endo USA, INC. | $22.84 | 2024 | Xiaflex |
| C. R. Bard, INC. & Subsidiaries | $22.50 | 2021 | |
| Ferring Pharmaceuticals INC. | $17.37 | 2019 | |
| Laborie Medical Technologies Corp. | $16.81 | 2022 | |
| Urogen Pharma, INC. | $14.74 | 2025 | |
| Novo Nordisk INC | $14.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.